Plunkett Research Online: ADL Partner

ADL PARTNER (APRTF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ASLAN Pharmaceuticals Ltd is a clinical-stage oncology-focused biotechnology company. It is developing novel therapeutics for global markets. The company's portfolio consists of four product candidates which target validated growth pathways applied to new patient segments and novel cancer metabolic .....



ADL Partner
Ticker: APRTF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 33 141587203
Fax: 33 141587053
Address: 35th Floor, 68 ZhongXiao E. Road
Sector 5, XinYi Dist
Taipei, 110 Taiwan

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription
Carl FirthChairman of the Board/Director/CEO
Bertil LindmarkChief Medical Officer
See More
ASLAN Pharmaceuticals Ltd is a clinical-stage oncology-focused biotechnology company. It is developing novel therapeutics for global markets. The company's portfolio consists of four product candidates which target validated growth pathways applied to new patient segments and novel cancer metabolic .....See More See More

Auditor:
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: